Skip to content

Clinical trials

Phase 1/2 Sarcoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 1/2 Country / region: Spain Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20131
20142
20165
20173
20181
20192
20203
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting5
Active, not recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Grupo Espanol de Investigacion en Sarcomas5
Eli Lilly and Company4
Turning Point Therapeutics, Inc.2
Celgene1
Clinica Universidad de Navarra, Universidad de Navarra1
Eisai Inc.1
Genmab1
Hoffmann-La Roche1
MedSIR1
Mundipharma Research Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma21
Neoplasm Metastasis4
Neoplasms4
Sarcoma, Ewing4
Carcinoma, Non-Small-Cell Lung3
Central Nervous System Neoplasms3
Endometrial Neoplasms3
Thyroid Neoplasms3
Breast Neoplasms2
Bronchial Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.